omniture

Mindray to Participate in Upcoming Investor Conferences and Events

2015-01-06 21:00 1473

SHENZHEN, China, January 6, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will present in four upcoming investor conferences and events.

Mr. Alex Lung, Mindray's Chief Financial Officer, will attend the 33rd Annual J.P. Morgan Healthcare Conference, which will be held on January 12-15, 2015 at the Westin St. Francis Hotel in San Francisco. Mr. Lung will present at 9:30 am PST on Wednesday, January 14, and will meet with investors from January 12 to January 14.

On January 12, 2015, Mr. Lung will also participate in the 4th Annual China Healthcare Dinner with C-Level Executives, co-organized by BioCentury, KPCB China, MayTech Capital Management, Morgan Stanley, Western Bridge, Sidley Austin LLP and L.E.K. Consulting in San Francisco.

Next will be the UBS Greater China Conference 2015, which will be held on January 12-14, 2015 at the Pudong Shangri-La Hotel in Shanghai. Mr. Cheng Minghe, Mindray's Co-Chief Executive Officer and Chief Strategic Officer, and Ms. Cathy Gao, Senior Manager of Investor Relations, will attend the conference on January 13.

Mr. Jianxin Wang, Mindray's Chief Operating Officer, and Ms. May Li, Chief Investment Officer, will participate in the 13th Annual DB Access China Conference, which will be held on January 12-14, 2015 at the Grand Hyatt Hotel in Beijing. Mr. Wang and Ms. Li will present at 9:00 am HKT on Wednesday, January 14, and will meet with investors on the same day.

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China, we supply through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostic, and medical imaging systems. For more information, please visit http://ir.mindray.com.

For investor and media inquiries, please contact:

In China:
Cathy Gao
Mindray Medical International Limited
Tel: +86-755-8188-8023
Email: cathy.gao@mindray.com

In the U.S:

Hoki Luk
Western Bridge, LLC
Tel: +1-646-808-9150
Email: hoki.luk@westernbridgegroup.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mindray-to-participate-in-upcoming-investor-conferences-and-events-300016243.html

Source: Mindray
collection